Abstract     Description     Claims  

US61180582B   [0001] 
US63754506   [0010] 
US637545   [0043]  [0054] 
WO2006056399A   [0060] 
US5521184A   [0063] 
WO04005281A   [0063] 
EP2005009967A   [0063] 
EP2005010408A   [0063] 
US578491   [0063] 
WO03037347A   [0064] 
WO03099771A   [0064] 
WO04046120A   [0064] 
WO0009495A   [0065] 
WO05028444A   [0065] 
WO04080980A   [0066] 
WO04056786A   [0066] 
WO03024967A   [0066] 
WO01064655A   [0066] 
WO00053595A   [0066] 
WO01014402A   [0066] 
WO2002000196A   [0074] 
US20070135461   [0174] 
US2006047369W   [0174] 
WO2007070514A   [0174] 

Arthritis Res   [0004] 
Cell   [0005] 
Neoplasm.   [0007] 
Oncogene   [0007] 
Cancer Cell   [0008] 
JCI   [0009] 
Adv Pharmacol.   [0009] 
Remington's Pharmaceutical Sciences   [0035] 
Journal of Pharmaceutical Science   [0035] 
Biochem. J.   [0049] 
J. Biol. Chem.   [0049] 
The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop   [0052] 
Handbook of pharmaceutical excipients   [0153]  [0154] 
Analytical Biochemistry   [0186] 
Nature   [0190] 
JBC   [0190] 
Hematol J.   [0192] 
Immunol Today   [0193] 
Agents Actions   [0193] 
Current Protocols in Immunology   [0196] 
Inflammation Protocols   [0196] 
Experimental Eye Research   [0197] 
Developmental Opthalmology   [0197] 
Immunology and Cell Biology   [0198] 
Allergy   [0199]